Morgan Stanley Reiterates Overweight Rating on DexCom (DXCM), 'Prelim Results Likely Clear the Bar'

January 12, 2026 9:04 AM EST Send to a Friend
Morgan Stanley analyst Patrick Wood reiterated an Overweight rating and $75.00 price target on DexCom (NASDAQ: DXCM).The analyst comments "Earlier ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login